Patents for A61P 11 - Drugs for disorders of the respiratory system (87,767)
10/2004
10/07/2004WO2004085650A1 A high-troughput diagnostic assay for the human virus causing severe acute respiratory syndrome (sars)
10/07/2004WO2004085633A1 A novel human virus causing severe acute respiratory syndrome (sars) and uses thereof
10/07/2004WO2004085477A1 Treatment of type 1 immune response-mediated inflammatory lung disease by modulation of ifn-gamma activity
10/07/2004WO2004085423A1 Piperidine derivatives for the treatment of chemokine or h1 mediated disease state
10/07/2004WO2004085388A2 Cyclic protein tyrosine kinase inhibitors
10/07/2004WO2004084934A1 Asthma preparation
10/07/2004WO2004084897A1 Synergistic combination comprising roflumilast and an anticholinergic agent selected from ipratropium, oxitropium and tiotropium salts for the treatment of respiratory diseases
10/07/2004WO2004084896A1 Synergistic combination comprising roflumilast and an anticholinergic agent selected from ipratropium, oxitropium and tiotropium salts for the treatment of respiratory diseases
10/07/2004WO2004084891A1 Methods for treating inflammatory conditions or inhibiting jnk
10/07/2004WO2004084890A1 Therapeutic and prophylactic compositions and uses therefor
10/07/2004WO2004002418A3 Compositions and methods comprising protein activated receptor antagonists
10/07/2004WO2003099195A3 Immunomodulatory compounds and methods of use thereof
10/07/2004WO2003053973A8 Pyrazolyl-substituted triazoloquinoxalines
10/07/2004WO2002088317A3 Fusion molecules and methods for treatment of immune diseases
10/07/2004US20040198979 antagonists of urotensin II; (R) N-[4-Chloro-3-(1-methyl-3-pyrrolidinyloxy)-phenyl]-[3-(2-chlorophenoxy)]benzenesulfonamide for example; treating various disease including cardiovascular disorders, gastrointestinal disorders, and psychological disorders
10/07/2004US20040198976 Method for synthesizing pyrazolobenzodiazepines
10/07/2004US20040198961 Fce fusion proteins for treatment of allergy and asthma
10/07/2004US20040198834 Concentrated X-ray contrast media can act as universal antigens and can inhibit or prevent allergic reactions
10/07/2004US20040198801 Antiinflammatory agents; sepsis
10/07/2004US20040198791 Fused imidazole derivative
10/07/2004US20040198781 Carbonic anhydrase inhibitor
10/07/2004US20040198749 Methods of using sodium channel blockers
10/07/2004US20040198748 Antihistamines; bronchodilators; antiinflammatory agents; inflammatory bowel disorders
10/07/2004US20040198747 Sodium channel blockers
10/07/2004US20040198746 Sodium channel blockers
10/07/2004US20040198745 Sodium channel blockers
10/07/2004US20040198744 Methods of using phenolic guanidine sodium channel blockers
10/07/2004US20040198737 Azaindoles
10/07/2004US20040198735 Sulfonyl heteroaryl triazoles as anti-inflammatory/analgesic agents
10/07/2004US20040198717 4-(trifluoromethyl)-7,8,9,10-tetrahydrochromeno[7,6-b]azepin-2(6H)-one and derivatives;4-(trifluoromethyl)-1,6,7,8,9,10-hexahydro-2H-azepino[3,2-g]quinolin-2-one and derivatives; useful in the treating conditions caused by androgen deficiency such as bone disorders
10/07/2004US20040198708 For orienting and positioning a capsule containing a dry powder pharmaceutical formulation ( a short-acting bronchodilator and a corticosteroid) to be administered via inhalation to a patient with a pulmonary disease
10/07/2004US20040198696 Agent and food for inhibiting IgE antibody
10/07/2004US20040198688 for treatment of atopic conditions (dermatitis, allergies); point mutations
10/07/2004US20040198686 Administering resistin-like molecules alpha or beta
10/07/2004US20040198677 macrolide and steroidal or non-steroidal substructures connected by an alkyl linker; esterification or amidation to couple; antiarthritic, antiasthmatic agents, nasal, gastrointestinal, dermatological and opthalmic disorders; veterinary or human therapy
10/07/2004US20040198651 Secreted proteins
10/07/2004US20040198633 Fungicide against Candida, Entomocorticum, Stereum, Phellinus, Peniophora, Xilaria, Rosellinia, Multiclavula, Hericium, and/or Tricholoma; flucytosine, miconazole,ketoconazole, fluconazole, amphotericin B extracted from culture of Streptomyces and/or nystatin
10/07/2004US20040197847 High throughput screening assays using fatty acid synthetic enzymes
10/07/2004US20040197429 Selective COX-2 inhibition from plant extracts
10/07/2004US20040197405 Multiparticulate modified release composition
10/07/2004US20040197345 Prostate derived Ets factor
10/07/2004US20040197341 Therapeutic process for p. aeruginosa infections using macrolide antibiotics
10/07/2004US20040197338 Sequening peptide fragments which bind to proteins; prevention reproduction of respiratory syncytial virus
10/07/2004US20040197273 Suspension aerosol formulations
10/07/2004US20040197271 Therapy for respiratory system disorders; mixture of adrenergic blocking agent, corticosteroid with propellant; side effect reduction
10/07/2004DE202004009037U1 Ointment for care and healing of dry and/or inflamed nasal mucosa comprises soya oil, pumpkinseed oil, an emulsifier, a fragrance and an ointment base
10/07/2004CA2520443A1 Methods for treating inflammatory conditions or inhibiting jnk
10/07/2004CA2519921A1 Asthma preparation
10/07/2004CA2519682A1 Synergistic combination comprising roflumilast and an anticholinergic agent selected from ipratropium, oxitropium and tiotropium salts for the treatment of respiratory diseases
10/07/2004CA2519313A1 Treatment of type 1 immune response-mediated inflammatory lung disease by modulation of ifn-gamma activity
10/06/2004EP1464330A1 Use of a composition containing oligosaccharides in combination with a saponine or a basic aminoacid, for topical administration or for inhalation
10/06/2004EP1463823A2 Methods of increasing endogenous erythropoietin (epo)
10/06/2004EP1463817A2 Histamine receptor h3 polynucleotides
10/06/2004EP1463756A2 Secreted proteins
10/06/2004EP1463716A1 Pyrrolidine and piperidine derivates as nk1 antagonists
10/06/2004EP1463714A2 Vanilloid receptor ligands and their use in treatments
10/06/2004EP1463707A2 A group of novel anti-cancer compounds with specific structure
10/06/2004EP1463553A1 Medicament dispenser
10/06/2004EP1463525A2 Compositions and methods for the diagnosis and treatment of tumor
10/06/2004EP1463522A1 Human antipneumococcal antibodies from non-human animals
10/06/2004EP1463519A2 Vaccine
10/06/2004EP1463509A1 Type 4 phosphodiesterase inhibitors and uses thereof
10/06/2004EP1463507A1 Thienopyrimidine compounds as protein tyrosine kinase inhibitors
10/06/2004EP1463498A1 Composition inhibiting matrix-metallproteinases for the treatment of neoplastic diseases
10/06/2004EP1463497A2 Treating muscle wasting with selective androgen receptor modulators
10/06/2004EP1463489A1 Composite dosage forms
10/06/2004EP1296981B1 Substituted pyrrolopyridinone derivatives useful as phosphodiesterase inhibitors
10/06/2004EP1248787B1 NOVEL SUBTITUTED PYRAZOLO[4,3-e]DIAZEPINES, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM, USE AS MEDICINAL PRODUCTS AND PROCESSES FOR PREPARING THEM
10/06/2004EP1210325B1 Aminobenzophenones as inhibitors of il-1beta and tnf-alpha
10/06/2004EP1165516B1 Heterocyclic urea and related compounds useful as anti-inflammatory agents
10/06/2004EP1161225B1 Metered dose inhalers with isobutane as propellant
10/06/2004EP1154993B1 Thioamide derivatives
10/06/2004EP1144403B1 Substituted pyrazoles as p38 kinase inhibitors
10/06/2004EP1133284B1 A process for the preparation of crystalline particles
10/06/2004EP1027336B1 Heteroaryl diazacycloalkanes as cholinergic ligands at nicotinic acetylcholine receptors
10/06/2004EP0869810B1 Cyclosporin-containing soft capsule preparations
10/06/2004CN2645668Y Plaster for allergic rhinitis
10/06/2004CN1535312A PUFA polyketide synthase systems and uses thereof
10/06/2004CN1535161A Adenosine A2A receptor agonist and anticholinergic agent in combination for treating obstructive airways diseases
10/06/2004CN1535147A Azolylcarbynol derivatives of aryl (or heteroaryl) for treatment of respiratory diseases
10/06/2004CN1534017A N-(2-phenyl-4-amino-batyl)-1-naphthol carboxy amide kind compound used as neuropeptide-1-acceptor antagonistic agent
10/06/2004CN1533808A Composition for treating coronavirus infection and SARS and method
10/06/2004CN1533772A Extraction method of Anhui fritillary extract
10/06/2004CN1533768A Leimaquban solid dispersion, prepation method and oral composition
10/06/2004CN1169791C Novel acetamide derivatives and protease inhibitors
10/06/2004CN1169768C (4-alkynyl), aromatic keto-acid compound, synthesis method and its application
10/06/2004CN1169568C External use medicine for treating allergic nasitis and preparing process thereof
10/06/2004CN1169567C Medicine for external application for curing infantile pneumonia and preparing method thereof
10/06/2004CN1169565C Medicine for treating throat disease and stomatopathy
10/06/2004CN1169560C Peach and apricot health-care food for curing cough and asthma
10/06/2004CN1169540C Medicated bag for curing tussis
10/06/2004CN1169524C Use of isotretinoin receptor antagonists for inhibition of mucin secretion and use of medicine for curing related diseases
10/06/2004CN1169520C Perforated microparticles and methods for use
10/05/2004US6800654 Substituted naphthyl indole derivatives as inhibitors of plasminogen activator inhibitor type-1 (PAI-1)
10/05/2004US6800645 Substituted azabicyclic compounds
10/05/2004US6800644 Nitrogen-containing heterocyclic compounds and medicaments containing the compounds
10/05/2004US6800643 Mixtures for organic compounds for the treatment of airway diseases
10/05/2004US6800633 Pyrrolo[2,3d]pyrimidine compositions and their use
10/05/2004US6800627 Central nervous system, cardiovascular and gastrointestinal disorders, diabetes inspidus, sleep apnea
10/05/2004US6800626 For therapy and prophylaxis of inflammatory diseases, autoimmune diseases, destructive bone disorders, proliferative disorders, infectious diseases, neurodegenerative diseases, allergies, reperfusion/ischemia in stroke, heart attacks, etc.